Xamoterol
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C16H25N3O5 |
Molar mass | 339.387 g/mol |
WikiDoc Resources for Xamoterol |
Articles |
---|
Most recent articles on Xamoterol |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Xamoterol at Clinical Trials.gov Clinical Trials on Xamoterol at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Xamoterol
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Xamoterol Discussion groups on Xamoterol Directions to Hospitals Treating Xamoterol Risk calculators and risk factors for Xamoterol
|
Healthcare Provider Resources |
Causes & Risk Factors for Xamoterol |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Xamoterol is a cardiac stimulant. It works by binding to the β1 adrenergic receptor. It is a 3rd generation adrenergic beta receptor partial agonist. It provides cardiac stimulation at rest but it acts as a blocker during exercise. [1]
References
- ↑ Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4. Page 163
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Beta-adrenergic agonists
- Cardiovascular Drugs
- Drug